Ensuring consistent accountability and reproducibility while providing clients with high quality outcomes and confidence in our services.
Ensuring consistent accountability and reproducibility while providing clients with high quality outcomes and confidence in our services.
Hudson Institute Cell Therapies is the only facility of its kind in Victoria outside the Melbourne CBD. Located within the Monash Medical Precinct, we have the advantage of being on the doorstep of clinicians at Monash Medical Centre and researchers at Hudson Institute and Monash University.
Current NATA ISO:15189 accreditation for cell processing services. No: 21322
Fully certified ISO8 clean room facilities.
Co-located ISO:15189 accredited cryopreservation capabilities.
Hudson Institute Cell Therapies is the only facility of its kind in Victoria outside the Melbourne CBD. Located within the Monash Medical Precinct, we have the advantage of being on the doorstep of clinicians at Monash Medical Centre and researchers at Hudson Institute and Monash University.
Current NATA ISO:15189 accreditation for cell processing services. No: 21322
Fully certified ISO8 clean room facilities.
Co-located ISO:15189 accredited cryopreservation capabilities.
Hudson Institute Cell Therapies is the only facility of its kind in Victoria outside the Melbourne CBD. Located within the Monash Medical Precinct, we have the advantage of being on the doorstep of clinicians at Monash Medical Centre and researchers at Hudson Institute and Monash University.
Fully certified ISO8 clean room facilities.
Co-located ISO:15189 accredited cryopreservation capabilities.
About Hudson Institute Cell Therapies
Hudson Institute Cell Therapies is an expert in Bone Marrow and Cord Blood Transplant Processing. In addition, HICT is capable of manufacturing minimally manipulated cellular therapy products (blood or tissue derived) for early phase HREC approved investigator lead clinical trials under the TGA CTN scheme.
Our Commitment to Quality
HICT is a NATA ISO15189 accredited facility. We are committed to providing the highest standard of services in the processing of cell therapy products. We adhere to internationally recognized quality management systems, ensuring the safe, efficient, and reliable processing of all biological materials.
Our expert team works diligently to deliver precision and excellence in every aspect of cell therapy processing, from preparation to cryopreservation. We place the utmost importance on maintaining strict controls for quality assurance, traceability, and patient safety, ensuring that every product processed at our facility meets the rigorous requirements for clinical use.
With state-of-the-art equipment and a dedicated, well-trained team, we focus on providing customized processing solutions that meet the unique needs of each client. Our facility is designed to provide a clean, monitored and controlled environment where the processing of cellular therapies is carried out under the highest safety and quality standards.
At HICT, quality isn’t just a standard—it’s the cornerstone of everything we do. We are here to support our clients in advancing the field of cellular therapies and improving patient outcomes through safe, effective, and compliant cellular therapies.
About Hudson Institute Cell Therapies
Hudson Institute Cell Therapies is an expert in Bone Marrow and Cord Blood Transplant Processing. In addition, HICT is capable of manufacturing minimally manipulated cellular therapy products (blood or tissue derived) for early phase HREC approved investigator lead clinical trials under the TGA CTN scheme.
Our Commitment to Quality
HICT is a NATA ISO15189 accredited facility. We are committed to providing the highest standard of services in the processing of cell therapy products. We adhere to internationally recognized quality management systems, ensuring the safe, efficient, and reliable processing of all biological materials.
Our expert team works diligently to deliver precision and excellence in every aspect of cell therapy processing, from preparation to cryopreservation. We place the utmost importance on maintaining strict controls for quality assurance, traceability, and patient safety, ensuring that every product processed at our facility meets the rigorous requirements for clinical use.
With state-of-the-art equipment and a dedicated, well-trained team, we focus on providing customized processing solutions that meet the unique needs of each client. Our facility is designed to provide a clean, monitored and controlled environment where the processing of cellular therapies is carried out under the highest safety and quality standards.
At HICT, quality isn’t just a standard—it’s the cornerstone of everything we do. We are here to support our clients in advancing the field of cellular therapies and improving patient outcomes through safe, effective, and compliant cellular therapies.
Meet the team
Dr Mirja Krause-Onwukwe
Service Operations and Quality Manager
Nancy Messino
Production Manager
Siow Teng Chan
Production Supervisor
Meet the team
Dr Mirja Krause-Onwukwe
Service Operations and Quality Manager
Nancy Messino
Production Manager
Siow Teng Chan
Siow Teng Chan Production Supervisor
Our partners and collaborators
- Monash Health
- NATA
- RCPA
- ICCBBA
- Johnson & Johnson
- Novartis
- Bristol Meyers Squibb
- Gilead
- Cell Care
- BMDI
- Monash Children’s Hospital
- RNAte
- Cartherics
- FACT
- The Ritchie Center
- Cerebral Palsy Alliance
- Cell Therapies
Our partners and collaborators
- Monash Health
- NATA
- RCPA
- ICCBBA
- Johnson & Johnson
- Novartis
- Bristol Meyers Squibb
- Gilead
- Cell Care
- BMDI
- Monash Children’s Hospital
- RNAte
- Cartherics
- FACT
- The Ritchie Center
- Cerebral Palsy Alliance
- Cell Therapies
